Gaingels

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.

David Beatty

Managing Partner

Jesse Curran

Principal

Nancy Fechnay

Venture Partner

Paul Grossinger

Founder

Todd Havill

Research Operations and Principal, Investment

Past deals in Wearables

Limbic

Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Healium

Seed Round in 2023
Healium is a technology company that develops mental fitness tools and immersive, bio-data-driven experiences to support self-management of anxiety, sleep issues, burnout, and overall well-being. The platform links real-time biometric data from wearables such as heart rate and brain activity via EEG headbands to personalized video or VR assets, producing reactive media escapes controlled by the user’s physiology. By integrating wearable devices and sensors, Healium delivers data-driven content that adapts to the user in real time, aiming to reduce anxiety, improve mood, and build resilience for individuals and organizations. Peer-reviewed studies have reported rapid mood benefits and anxiety reduction in as little as four minutes.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.

STRIVE

Series A in 2022
STRIVE provides a platform that uses sensors in compression shorts to gather muscle movement data via surface electromyography (sEMG) and accelerometers. This data helps athletes, military personnel, and industrial workers track muscle activity, monitor fatigue, prevent injuries, and enhance performance.

OxiWear

Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices specifically designed for continuous oxygen monitoring and emergency alerting, targeting patients prone to silent hypoxia due to conditions such as pulmonary hypertension, high-altitude environments, high-intensity cardio activities, and COVID-19. The company's patented pulse oximeter offers a novel approach to monitoring oxygen levels, facilitating use in both clinical and consumer settings. By providing real-time data and alerts, OxiWear's technology enhances patient safety and peace of mind, ensuring timely medical assistance when needed.

Ruth Health

Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.

Zeit Medical

Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

Silvertree

Seed Round in 2021
Silvertree develops stylish, wearable technology designed for active seniors aged 65 and above. Their wrist-worn device prioritizes safety and fosters intergenerational connections, empowering users to maintain independence while providing peace of mind for loved ones.

Ruth Health

Pre Seed Round in 2021
Ruth Health is a telehealth provider specializing in women's health and prenatal care. They empower parents through evidence-based expertise, enhancing accessibility and affordability of childbirth services.

Genies

Series B in 2021
Genies empowers individuals to create personalized digital avatars for expression across social media and messaging platforms. It offers tools for users to design avatars, avatar fashion lines, worlds, and interactive experiences, enabling brands to drive engagement through exclusive digital goods.

Willow

Series C in 2021
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.

Feel Therapeutics

Seed Round in 2021
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

Sepsis Scout

Seed Round in 2019
Sepsis Scout is a developer of a wearable patch designed to predict the onset of sepsis in high-risk patients in home care settings. Utilizing proprietary deep learning technology, the device aims to detect sepsis more accurately than current standards of care. By enabling patients to manage chronic illnesses effectively, Sepsis Scout's solution helps individuals stay out of the hospital and alleviates the fear and uncertainty associated with serious health conditions. The company's focus on artificial intelligence and wearables positions it at the forefront of innovative healthcare solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.